The programme allows for new or existing clients to increase the time or bandwidth they use by multiples of up to 10 to meet needs as they arise. The new program is available as an on-premise, hybrid or cloud-based solution.
In recent weeks, many organisations have exponentially increased their demand for video communication platforms.
Vidyo's track record of supporting large health organisations, as well as major financial corporations, government agencies and educational institutions, positions it as an ideal solution for rapidly evolving contingency plans.
Specifically, the Vidyo Telehealth solution enables clinics and hospitals to protect front-line staff and patients by supporting self-isolation and quarantine scenarios, and ensures clinicians, nurses and physicians can provide remote diagnoses and treatments, often with existing technology.
Vidyo enriches people's lives by embedding real-time video into digital communications in the moments that matter most.
Millions of people around the world connect visually every day through Vidyo's secure, scalable technology and cloud-based services.
Its patented platform integrates with virtually any application environment, network and device to deliver the highest quality experiences that strengthen teams, build trust, solidify relationships, and improve quality of life.
QT Imaging signs exclusive USD33m distribution deal with Gulf Medical in Saudi Arabia
Novocure submits FDA PMA for Tumor Treating Fields therapy in pancreatic cancer
Covalon Technologies secures DTC eligibility to expand US investor access
Navamedic ASA secures final approvals for Flexilev in OraFID across Nordic markets
Oncopeptides partners with SD Pharma to expand Pepaxti access in Spain
Aptar launches bio-based nasal spray pump with Haleon's Otrivin brand
MAP Medical agrees distribution deal with Metrix-Secure
PharmaJet signs MOU with Egyptian UPA and EVA Pharma to introduce needle-free vaccine delivery
Alcon to acquire LumiThera and its FDA-authorised photobiomodulation device for dry AMD treatment
Predictmedix AI launches mobile diabetes screening platform in India
Navamedic's medical device OraFID approved as primary package for a pharmaceutical product
Speranza Therapeutics partners with Sunshine Labs for harm reduction solutions
Immuno Cure and PharmaJet collaborate for novel HIV therapeutic DNA vaccine advancement